Bicycle Therapeutics Plc (BCYC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bicycle Therapeutics Plc  (NASDAQ: BCYC)


Bicycle Therapeutics Plc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bicycle Therapeutics Plc's ROI in the second quarter of 2026?
Bicycle Therapeutics Plc recorded a cumulative net loss of $-190 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -30.26%.

Within the Healthcare sector 360 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3239 to 3511.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -25.91 % -25.22 % -10.94 % 8.01 % 33.45 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 559 604 661 694 753
Return On Investment (TTM) -30.26 % -32.32 % -29.88 % -31.77 % -28.54 %
BCYC's Overall Ranking # 3511 # 3239 # 3112 # 3292 # 2232
Seq. Investment Change TTM -7.16 % -7.51 % -7.13 % -7.1 % -6.29 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -190 -219 -219 -251 -242

BCYC Company Profile >> Back to BCYC Roi Comparisons >> See Annual BCYC Return On Investment



Return On Investment BCYC's Ranking
Within: No.
Industry # 141
Sector # 361
Overall # 3511

Return On Investment Statistics
High Average Low
-20.39 %
-31.32 %
-45.77 %
(Dec 31 2024)   (Dec 31 2019)







Financial Statements
Bicycle Therapeutics Plc's II. Quarter Investments $ 559 Millions BCYC's Balance sheet
Bicycle Therapeutics Plc's II. Quarter Income $ -50 Millions Quarterly BCYC's Income Statement
BCYC's Income by Division See BCYC's Income by Division


BCYC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 647 886 516 346 431
Y / Y Investment Growth -27 % 71.5 % 49.09 % -19.72 % 213.58 %
Net Income in Millions -219 -169 -181 -113 -67
Y / Y Net Income Growth - - - - -
Annual Return On Investment -33.87 % -19.09 % -34.98 % -32.54 % -15.49 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BCYC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BCYC's Competitors
Subscribers only: Roi for Bicycle Therapeutics Plc's Suppliers
Subscribers only: Return On Investment for BCYC's Customers

Other Ratios
BCYC's Roa BCYC's Inventory Turnover Ratio BCYC's Growth Rates BCYC's Dividend Statistics
BCYC's Profitability Ratios BCYC's Asset Turnover Ratio BCYC's Dividend Growth
BCYC's Roe BCYC's Valuation Ratios BCYC's Financial Strength Ratios BCYC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-14T03:48:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.